IBA Secures €35M–€45M Contract for Rome’s First Proton Therapy Center
Event summary
- IBA SA signed a contract with IFO to install Rome’s first gantry-based proton therapy center, a €35M–€45M turnkey project.
- The Proteus®ONE system will be delivered by 2030, marking the first such facility in central and southern Italy.
- IBA partners Cecchini SRL and Gowen SRL will support construction and installation.
- IFO will use the system for both pediatric and adult cancer treatments.
The big picture
IBA’s contract with IFO underscores the growing demand for advanced cancer treatment infrastructure in Italy, particularly in regions lacking proton therapy access. The deal reinforces IBA’s leadership in compact gantry-based systems, a segment critical for expanding treatment availability. With a typical system price ranging from €35M to €45M, this project highlights the high-stakes, high-reward nature of medical technology investments in oncology.
What we're watching
- Market Expansion
- Whether IBA can leverage this contract to secure similar deals in other underserved regions.
- Execution Risk
- The pace at which IBA and its partners complete the installation and training program by 2030.
- Competitive Dynamics
- How this move affects IBA’s positioning against other proton therapy providers in Europe.